CoChat

Regulation of the inducible cyclo‐oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide

Open access
Neil Watkins, D, Garlepp, Michael J, Thompson, Philip J · 1997 · British Journal of Pharmacology
Cited by 117

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

In airway epithelium, nitric oxide (NO) is synthesized in the setting of inflammation by inducible nitric oxide synthase (iNOS). Although the role of epithelial derived NO in the regulation of human airways is unknown, prostaglandin E 2 (PGE 2) is recognised as an important inhibitory mediator in human airways. Cyclo‐oxygenase (COX) is the rate limiting enzyme in the production of prostanoids and since inflammatory pathways enhance the expression of an inducible COX (COX‐2), both COX‐2 and iNOS may be co‐expressed in response to an inflammatory stimulus. Although regulation of the COX‐2 pathway by NO has been demonstrated in animal models, its potential importance in human airway epithelium has not been investigated. The effect of endogenous and exogenous NO on the COX‐2 pathway was investigated in the A549 human airway epithelial cell culture model. Activity of the COX‐2 pathway was assessed by PGE 2 EIA, and iNOS pathway activity by nitrite assay. A combination cytokine stimulus of interferon gamma (IFNγ) 100 u ml−1, interleukin‐1β (IL‐1β) 1 u ml−1 and lipopolysaccharide (LPS) 10 μg ml−1 induced nitrite formation which could be inhibited by the competitive NOS inhibitor N G‐nitro‐L‐arginine‐methyl‐ester (L‐NAME). IL‐1β alone (1–50 u ml−1) induced PGE 2 formation without significant nitrite formation, a response which was inhibited by the COX‐2 specific inhibitor nimesulide. Submaximal stimuli used for further experiments were IFNγ 100 u ml−1, IL‐1β 1 u ml−1 and LPS 10 μg ml−1 to induce both the iNOS and COX‐2 pathways, and IL‐1β 3 u ml−1 to induce COX‐2 without iNOS activity. Cells treated with IFNγ 100 u ml−1, IL‐1β 1 u ml−1 and LPS 10 μg ml−1 for 48 h either alone, or with the addition of L‐NAME (0 to 10−2 M), demonstrated inhibition by L‐NAME of PGE 2 (3.61±0.55 to 0.51±0.04 pg/10 4 cells; P<0.001) and nitrite (34.33±8.07 to 0 pmol/10 4 cells; P<0.001) production. Restoration of the PGE 2 response (0.187±0.053 to 15.46±2.59 pg/10 4 cells; P<0.001) was observed after treating cells with the same cytokine stimulus and L‐NAME 10−6 M, but with the addition of the NOS substrate L‐arginine (0 to 10−5 M). Cells incubated with IL‐1β 3 u ml−1 for 6 h, either alone or with addition of the NO donor S‐nitroso‐acetyl‐penicillamine (SNAP) (0 to 10−4 M), demonstrated increased PGE 2 formation (1.23±0.03 to 2.92±0.19 pg/10 4 cells; P< 0.05). No increase in PGE 2 formation was seen when the experiment was repeated in the presence of the guanylate cyclase inhibitor methylene blue (50 μ M). Cells treated with SNAP alone did not demonstrate an increased PGE 2 formation. Cells incubated with IL‐1β 3 u ml−1 for 6 h in the presence of dibutyryl cyclic guanylate monophosphate (0 to 10−3 M) also demonstrated an increased PGE 2 response (2.56±0.21 to 4.53±0.64 pg/10 4 cells; P<0.05). These data demonstrate that in a human airway epithelial cell culture system, both exogenous and endogenous NO increase the activity of the COX‐2 pathway in the setting of inflammatory cytokine stimulation, and that this effect is likely to be mediated by guanylate cyclase. This suggests a role for NO in the regulation of human airway inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0701283

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 117

Metadata

Authors
Neil Watkins, D., Garlepp, M. J., & Thompson, P. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1997-07
Volume
121
Issue
7
Pages
1482-1488
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2081642488
Cited by
117
References
2
FWCI
6.90
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.